Interestingly, IFN-γ promotes conversion of immunogenic DCs into IDO+ tolerogenic DCs by inducing IDO1 expression, thus limiting the extent of anti-tumor immunity [102,103]. The gene discussed is IDO1; the disease is neoplasm.